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ABSTRACT 
Background: Breast cancer remains a leading cause of death in women worldwide. Although 
breast cancer therapies have greatly advanced in recent years, many patients still develop 
tumour recurrence and metastasis, and eventually succumb to the disease due to 
chemoresistance. Citral has been reported to show cytotoxic effect on various cancer cell lines. 
However, the potential of citral to specifically target the drug resistant breast cancer cells has 
not yet been tested, which was the focus of our current study. 
Methods: The cytotoxic activity of citral was first tested on MDA-MB-231 cells in vitro by 
MTT assay. Subsequently, spheroids of MDA-MB-231 breast cancer cells were developed and 
treated with citral at different concentrations. Doxorubicin, cisplatin and tamoxifen were used 
as positive controls to evaluate the drug resistance phenotype of MDA-MB-231 spheroids. In 
addition, apoptosis study was performed using AnnexinV/7AAD flowcytometry. Aldefluor 
assay was also carried out to examine whether citral could inhibit the ALDH-positive 
population, while the potential mechanism of the effect of citral was carried out by using 
quantitative real time- PCR followed by western blotting analysis. 
Results: Citral was able to inhibit the growth of the MDA-MB-231 spheroids when compared 
to a monolayer culture of MDA-MB-231 cells at a lower IC50 value. To confirm the inhibition 
of spheroid self-renewal capacity, the primary spheroids were then cultured to additional 
passages in the absence of citral. A significant reduction in the number of secondary spheroids 
were formed, suggesting the reduction of self-renewal capacity of these aldehyde 
dehydrogenase positive (ALDH+) drug resistant spheroids. Moreover, the AnnexinV/7AAD 
results demonstrated that citral induced both early and late apoptotic changes in a dose-
dependent manner compared to the vehicle control. Furthermore, citral treated spheroids 
showed lower cell renewal capacity compared to the vehicle control spheroids in the 
mammosphere formation assay. Gene expression studies using quantitative real time PCR and 
Western blotting assays showed that citral was able to suppress the self-renewal capacity of 
spheroids and downregulate the Wnt/β-catenin pathway. 
Conclusion: The results suggest that citral could be a potential new agent which can eliminate 
drug-resistant breast cancer cells in a spheroid model via inducing apoptosis. 
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